,,ii  #aah? ,,congress  #b;d ,session   
,s4 #dfce  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,july #h1 #bjbd,mr4    
,pet]s 7= himself & ,ms4 ,ern/7         
introduc$ ! foll[+ bill2 :i* 0 read     
twice & ref]r$ to ! ,committee on ,arm$ 
,s]vices  ,a ,,bill  ,to require a      
report & updat$ guidance on cont9u$ risk
 managem5t = ph>maceutical supply *a9s (
 ,dep>tm5t ( ,def5se4  #a4 ,%ort title  
,?is ,act may be cit$ z ! ,ph>maceutical
 ,risk ,assessm5t & ,mitigation ,act (  
#bjbd4  #b4 ,report & updat$ guidance on
 cont9u$ risk managem5t = ph>maceutical 
supply *a9s ( ,dep>tm5t ( ,def5se  7a7  
,9 g5]al ,n lat] ?an two ye>s aft] !    
date ( ! enactm5t ( ?is ,act1 ! ,"u     
,secret>y ( ,def5se = ,acquisition &    
,su/a9m5t %all-- 7#a7 submit to !       
,committees on ,arm$ ,s]vices ( ! ,s5ate
 & ! ,h\se ( ,repres5tatives a report   
reg>d+-- 7,a7 exi/+ in=mation /reams )9 
! ,f$]al ,gov]nm5t1 if any1 = excipi5ts 
& key />t+ mat]ials ( drugs t may be us$
 to assess ! reliance by ! ,dep>tm5t (  

,def5se on high-risk =eign suppli]s     
analyz$ 9 ! report requir$ "u section   
#hfj7;a7 ( ! ,james ,m4 ,inh(e ,national
 ,def5se ,au?orization ,act = ,fiscal   
,ye> #bjbc 7,public ,law #aag-bfc2 #aj  
,u4,s4,c4 #cbda note prec472  7,b7      
active ph>maceutical +r$i5ts1 f9al drug 
products1 & respective excipi5ts & key  
/>t+ mat]ials analyz$ 9 su* report t is 
produc$ by ea* manufactur] 9 a high-risk
 =eign c\ntry1 z det]m9$ by ! ,secret>y 
( ,def5se2  7,c7 any limitations on !   
ability ( ! ,secret>y to-- 7i7 obta9 or 
analyze ! in=mation id5tifi$ "u         
subp>agraphs 7,a7 & 7,b72 &  7ii7 use   
data analytics to monitor vuln]abilities
 9 ! ph>maceutical supply *a9 ( !       
,dep>tm5t2  7,d7 h[ ! ,secret>y plans to
 address ! limitations id5tifi$ "u      
subp>agraph 7,c72 &  7,e7 any           
recomm5dations ( ! ,secret>y to address 
^? limitations2 &  7#b7 update risk     
managem5t guidance develop$ by ! ,"u    
,secret>y "u section #hfj7;a77#a7 ( !   
,james ,m4 ,inh(e ,national ,def5se     

,au?orization ,act = ,fiscal ,ye> #bjbc 
7,public ,law #aag-bfc2 #aj ,u4,s4,c4   
#cbda note prec47 to include any        
relevant f9d+s id5tifi$ 9 p>agraph 7#a74
  7b7 ,,fda det]m9ations ,! ,dep>tm5t ( 
,def5se %all rely ^u det]m9ations (     
excipi5ts & key />t+ mat]ials = f9al    
drug products t are made by ! ,food &   
,drug ,adm9i/ration 7,,fda7 or t align )
 ,,fda regulations4